<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01157585</url>
  </required_header>
  <id_info>
    <org_study_id>CBIRB0912-141</org_study_id>
    <nct_id>NCT01157585</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Paliperidone ER in First Episode Psychosis</brief_title>
  <official_title>Efficacy and Safety of Paliperidone ER in Patients With First Episode Psychosis: an Open-label, Prospective Multi-center Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chonbuk National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Janssen Korea, Ltd., Korea</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Chonbuk National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate the efficacy and safety of Paliperidone ER in patients
      with first episode psychosis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Symptoms assessment by objective rating scales</measure>
    <time_frame>week 1</time_frame>
    <description>PANSS total score, SANS, CGI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptoms assessment by objective rating scales</measure>
    <time_frame>week 2</time_frame>
    <description>PANSS total score, SANS, CGI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptoms assessment by objective rating scales</measure>
    <time_frame>week 3</time_frame>
    <description>PANSS total score, SANS, CGI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptoms assessment by objective rating scales</measure>
    <time_frame>week 4</time_frame>
    <description>PANSS total score, SANS, CGI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptoms assessment by objective rating scales</measure>
    <time_frame>week 8</time_frame>
    <description>PANSS total score, SANS, CGI, CAI(Cognitive Assessment Interview)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of adverse events by objective rating scales and self report scales profile</measure>
    <time_frame>week 1</time_frame>
    <description>NIDSS(Neuroleptic induced deficit syndrome scale), BAS, SAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of adverse events by objective rating scales and self report scales</measure>
    <time_frame>week 2</time_frame>
    <description>NIDSS(Neuroleptic induced deficit syndrome scale), BAS, SAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of adverse events by objective rating scales and self report scales</measure>
    <time_frame>week 4</time_frame>
    <description>NIDSS(Neuroleptic induced deficit syndrome scale), BAS, SAS, AIMS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of adverse events by objective rating scales and self report scales</measure>
    <time_frame>week 8</time_frame>
    <description>NIDSS(Neuroleptic induced deficit syndrome scale), BAS, SAS, AIMS, Lipid profile</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>First Episode Psychosis</condition>
  <arm_group>
    <arm_group_label>drug</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paliperidone ER</intervention_name>
    <description>8 week prospective study</description>
    <arm_group_label>drug</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18-59 years and meet DSM-IV diagnostic criteria for first episode of
             schizophrenia, schizophreniform disorder, schizoaffective disorder or psychotic
             disorder NOS as assessed by using the Structured Clinical Interview for DSM-IV,
             research version.

        Exclusion Criteria:

          -  Meeting DSM-IV criteria for another axis I diagnosis, including substance abuse or
             dependence

          -  Needing another nonantipsychotic psychotropic medication at enrollment

          -  Having a serious or unstable medical illness.

          -  Pregnant or lactating women or women without adequate contraception will be also
             excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Psychiatry, Korea University College of Medicine, Ansan Hospital</name>
      <address>
        <city>Ansan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Psychiatry, Kangwon National University College of Medicine</name>
      <address>
        <city>Chunchon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Psychiatry, Kyungpook national University School of Medicine</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Psychiatry, Eulji University, School of Medicine</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Psychiatry, Chonnam National University Medical School</name>
      <address>
        <city>Hwasun</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Psychiatry, College of Medicine, Won-Kwang University</name>
      <address>
        <city>Iksan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Psychiatry, Gachon University of Medicine and Science</name>
      <address>
        <city>Incheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Psychiatry, Chonbuk national University Hospital</name>
      <address>
        <city>Jeonju</city>
        <zip>561-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Psychiatry, Myongji Hospital Kwandong Uni. college of Medicine</name>
      <address>
        <city>Koyang</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. John of God Neuropsychiatric Hospital</name>
      <address>
        <city>Kwangju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>department of Neuropsychiatry. Dong-Eui University Medical Center</name>
      <address>
        <city>Pusan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neuropsychiatry, Soonchunhyang University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2010</study_first_submitted>
  <study_first_submitted_qc>July 6, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2010</study_first_posted>
  <last_update_submitted>July 30, 2015</last_update_submitted>
  <last_update_submitted_qc>July 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 31, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chonbuk National University Hospital</investigator_affiliation>
    <investigator_full_name>Young Chul Chung</investigator_full_name>
    <investigator_title>Professor of Psychiatry</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychotic Disorders</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paliperidone Palmitate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

